3 - Anti-Epileptic Drugs Flashcards
Seizure Defined
Transient altercation of behavior due to the disorderd, synchronous and rhythmic of brain neurons; sustained depolarization
Epilepsy Defined
Disorder of brain function characterized by the periodic and unpredictable occurrence of seizures
Epilepsy Classification/Generalized Seizures: Generalized Tonic Clonic (Both Hemispheres/Grand Mal): Tonic Phase (4)
Incontinence
Epileptic Cry
Cyanosis
Generalized stiffening of body and limbs, back arched
Epilepsy Classification/Generalized Seizures: Generalized Tonic Clonic (Both Hemispheres/Grand Mal): Clonic Phase (4)
Cyanosis
Eyes Blinking
Salivary Frothing
Clinic jerks of limbs, body and head
Epilepsy Classification/Generalized Seizures: Generalized Tonic Clonic (Grand Mal): Post-Ictal Confusional Fatigue (1)
Limbs and body limp
Epilepsy Classification/Generalized Seizures: Absence Seizures Defined (2)
Between seizures patient is normal
During Seizure: vacant stare, eyes roll up, eyelids flutter (3/seconds), cessation of activity, lack of response ; LOC
Epilepsy Classification/Generalized Seizures: Other (2)
Myoclonic Seizures –> shock like jerk of a group of muscle, no LOC
Atonic Seizures –> NO LOC
Partial Seizures: Simple Partial Seizures Defined
Originate from a single cortical side/single hemisphere
NO LOC, stiffening or jerking movements of limp
Partial Seizures: Complex Partial Seizures (Temporal Lobe Epilepsy/Psychomotor Seizures)
Originates in temporal lobe and involves limbic system
Hallucinations, aura signaling onset, autamatism (purposeless actions)
Localized onset, can involve both hemisphere
Partial Seizures: Partial with Secondarily Generalized (1)
Begins focally from a single cortical side and can become generalized
Epileptic Drugs: Phenobarbitone MOA (2)
Potentiation of synaptic inhibition through an action on GABA-A receptor; prolongs DURATION of channel opening events
Enhances GABA receptor mediated current by prolonging the opening of Cl- channels
Epileptic Drugs: Phenobarbitone At Higher Levels - MOA
Limits sustained repetitive firing of neurons through an action on Na+ conductance
Inhibits Ca2+ currents
Epileptic Drugs: Phenobarbitone Toxicity (5)
Sedation, initially
Nystagmus and Ataxia
Rashes
Megaloblastic anemia (long term use, interference with folic acid metabolism)
Osteomalacia (Vitamin D and K metabolism enhanced)
Epileptic Drugs: Phenobarbitone Use (4)
Generalized Tonic Clonic
Simple Partial
Complex Partial
3rd line drug for Status Epilepticus (IM/IV)
Epileptic Drugs: Phenytoin Mechanism (2)
Limits the sustained high frequency repetitive firing of action potentials
Slows the rate of recovery of voltage activated Na+ channels from inactivation (channels are inactivated for longer time)
Epileptic Drugs: Phenytoin Pharmacokinetics Low Doses (1) High Doses (1) and Implication (1)
Low doses: metabolism is capacity limited, follows first order kinetics (saturation kinetics; as you increase the dose, the metabolism also keeps up)
High doses: follows zero order kinetics (metabolism gets saturated, can’t keep up with increasing disease)
Implies that small increase may lead to disproportionate plasma levels; shifts kinetics
Epileptic Drugs: Phenytoin Adverse Affects at Therapeutic Levels (10-20 mcg/ml) (6)
Gum atrophy
Hirsutism (long term use)
Hypersensitivity Reactions (rashes, DLE, LAD)
Fetal Hydantoin Syndrome (contraindicated in pregnancy) –> cleft lip, etc.
Megaloblastic Anemia
Osteomalacia